Publication | Closed Access

Tumor-infiltrating CD8+ and FOXP3+ lymphocytes in triple-negative breast cancer: its correlation with pathological complete response to neoadjuvant chemotherapy

Breast OncologyMedicineImmunologyTumor ImmunityImmune Checkpoint InhibitorBreast CancerTriple-negative Breast CancerCancer TreatmentImmunotherapyOncologyCell BiologyTumor MicroenvironmentTumor BiologyNeoadjuvant ChemotherapyTumor-infiltrating Cd8+